Epiceram Coupon

Dermatitis is more than just dehydrated skins.

The EpiCeram Control Release Skin Safety Emulsion is a proprietary ethical dermatological safety formulation designed for the prevention and management of neurodermatitis. The EpiCeram contains 3 lipid-Ceramide, CLA ( konjugated lipoic acid) and Cholesterin in a physiological balance, 3:1:1 proportion. EpiCeram is singularly designed to improve dermal barriers and is also steroid-free, fragrance-free, non-comedogenic, 1 paraben-free and free of propane ethylene glycol. 1.

The EpiCeram Skin Barrier Emulsion is used to remove blemishes from dehydrated skins and to reduce and alleviate burns and pruritus associated with various kinds of dermatosis, neurodermatitis, irritant tactile and radiative eczema. With EpiCeram, you can help reduce the strain on your dehydrated, wax-like skins by preserving a damp surrounding of wounds and skins that is conducive to the recovery proces.

The EpiCeram feeds the surrounding tissue to support the recovery processes in neurodermatitis sufferers. Wiping the cream onto the scalp activates this two-stage application system. When EpiCeram is administered, a thin coat is applied to the affected area twice daily (or as needed) and massaged lightly into the area.

In case of fractures, the affected area should be dressed with a bandage of your own choosing after the procedure. The EpiCeram Skinrier Emulsion Control Release is an emulsion for the management of EpiCeram Control Release. EpiCeram Control Release helps to correct anomalies of the EpiCeram Control Release Skinrier. EpiCeram thus differentiates itself from other drugs such as correticosteroids and topically immunomodulating drugs by targeting the outside-in pattern of neurodermatitis pathophysiology.

While EpiCeram may be used in adult and child care, there are no limitations on ages for the use of EpiCeram Controlled Release Skin Barrier Emulsion. Yes, EpiCeram can be applied to the face and wrinkles. EpiCeram is not subject to any limitations in terms of either site or use. The researchers randomised 121 paediatric subjects with moderately to severely diagnosed acute respiratory distress to obtain EpiCeram or fluoresticasone proponate 0.05% creme in a randomised, five-centre, prospective, five-centre, blind trial.

EpiCeram Certified Release Skin Barrier Emulsion reduces the seriousness of the underlying condition, reduces itching and improves sleeping patterns both 14 and 28 day after commencement of use. Whereas fluid-sasone medicated subjects saw a faster increase in these parameter after 14 day, both EpiCeram Skin Barrier Emulsion and Low-fl uticasone showed similar increases in recovery from stress, itching and sleeping patterns.

The EpiCeram Controlled Release Skin Barrier Emulsion contains no solar protection and should always be used in combination with solar protection in areas subject to the outdoors. To be used in case of radiated skin dermatitis and/or in connection with radiotherapy after radiotherapy. Not to be used within 4 h before radiotherapy. Use twice a day or as directed by the radiotherapist.

After EpiCeram use, a transient prickle may appear (10-15 minutes). The EpiCeram controlled release skin barrier emulsion is available in a 90g tubing and a 225g bubble free vacuum tub.